Bayer's profit falls on $462 million in one-time costs

Share with others:

Print Email Read Later

Profit at Bayer AG fell by 18 percent in the third quarter as a result of special items totaling $462 million that include accounting costs for settling claims related to Bayer's Yasmin oral contraceptives.

Profit for the German-based pharmaceutical and chemical maker was $685 million. But earnings before special items rose by 2 percent to $2.39 billion just beating analysts' estimates of $2.38 billion.

Strong business in Bayer's health care and crop science segments helped boost global sales by nearly 12 percent to $12.6 billion.

In North America, sales jumped 9 percent to $2.9 billion.

The U.S. headquarters for Bayer MaterialScience is based in Robinson along with some U.S. headquarters personnel.

Also today, Bayer said it has an agreement to buy Salt Lake City-based Schiff Nutrition International, a vitamin and nutritional supplement maker, for $1.1 billion.

Marijn Dekkers, Bayer's chief executive, said the acquisition is part of Bayer's strategy to grow its life sciences business by purchasing small- and mid-sized companies.

Schiff expects more than 40 percent growth in sales this year following its acquisition of Airborne, an herbal and vitamin cold supplement touted as a cold remedy.

mobilehome - breaking - businessnews - neigh_west

Joyce Gannon: or 412-263-1580.

Create a free PG account.
Already have an account?

You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here